Mineralys Therapeutics Inc. (MLYS)
MLYS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$21.00
-5.53% on the day
Market cap
$1.9B
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MLYS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2023 |
| SEC CIK | 0001933414 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DELAWARE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-03 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-11 |
| Latest proxy | DEFA14A | 2026-04-08 |
Source: SEC EDGAR submissions feed, 400 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -6.1% |
| 1 month | -28.3% |
| 3 months | -23.4% |
| Year to date | -42.8% |
| 1 year | -51.8% |
| From 52-week high | -56.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc. | $10.20 | -2.49% | $1.9B |
| PVLA | Palvella Therapeutics Inc. | $128.51 | -4.37% | $1.9B |
| URGN | UroGen Pharma Ltd. | $38.26 | -0.05% | $1.9B |
| ADRX | ADARx Pharmaceuticals Inc. | $17.70 | -1.50% | $1.9B |
| AGIO | Agios Pharmaceuticals Inc. | $30.21 | -1.98% | $1.8B |
| LKFT | Lakefront Biotherapeutics | $29.05 | -1.76% | $1.9B |
| VERA | Vera Therapeutics Inc. | $26.79 | -3.35% | $1.9B |
| SDGR | Schrodinger Inc. | $25.89 | -0.08% | $1.9B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier